EW
Edwards Lifesciences CorpNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$47.45B
P/E Ratio
45.13
EPS
$1.81
Beta
0.93
52W High
$87.89
52W Low
$65.94
50-Day MA
$82.43
200-Day MA
$80.42
Dividend Yield
—
Profit Margin
17.70%
Forward P/E
27.93
PEG Ratio
2.13
About Edwards Lifesciences Corp
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Fundamentals
| Revenue (TTM) | $6.07B |
| Gross Profit (TTM) | $4.73B |
| EBITDA | $1.79B |
| Operating Margin | 23.70% |
| Return on Equity | 10.30% |
| Return on Assets | 7.65% |
| Revenue/Share (TTM) | $10.38 |
| Book Value | $17.80 |
| Price-to-Book | 4.63 |
| Price-to-Sales (TTM) | 7.82 |
| EV/Revenue | 7.32 |
| EV/EBITDA | 30.62 |
| Quarterly Earnings Growth (YoY) | -76.60% |
| Quarterly Revenue Growth (YoY) | 13.30% |
| Shares Outstanding | $580.80M |
| Float | $579.03M |
| % Insiders | 0.92% |
| % Institutions | 91.56% |
Historical Volatility
HV 10-Day
24.78%
HV 20-Day
28.47%
HV 30-Day
30.54%
HV 60-Day
26.47%
HV Rank
88.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($96.85 target)
5
Strong Buy16
Buy12
HoldData last updated: 3/25/2026